Prostatis Group Portfolio holdings
Top Buys
| 1 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$8.24M |
| 2 |
iShares MSCI KLD 400 Social ETF
DSI
|
+$5.84M |
| 3 |
iShares ESG Optimized MSCI USA ETF
SUSA
|
+$3.69M |
| 4 |
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
|
+$3.16M |
| 5 |
Pacer Trendpilot US Bond ETF
PTBD
|
+$3.11M |
Top Sells
| 1 |
Vanguard Value ETF
VTV
|
+$10.3M |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$5.42M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
+$5.23M |
| 4 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$3.87M |
| 5 |
Vanguard Small-Cap ETF
VB
|
+$2.31M |
Sector Composition
| 1 | Technology | 4.6% |
| 2 | Healthcare | 3.28% |
| 3 | Consumer Discretionary | 2.3% |
| 4 | Communication Services | 2.24% |
| 5 | Financials | 1.88% |
Similar funds
Prostatis Group's Q1 2021 Portfolio in Review
As of Q1 2021, Prostatis Group held 102 positions worth $127M, up 6.7% from $119M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Prostatis Group deployed $4.13M of net new capital in Q1 2021, opening 27 new positions and adding to 32 existing holdings. Its largest new stake was iShares ESG Aware MSCI USA ETF: 92,737 shares worth $8.43M.
By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 4.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Value ETF, an estimated $10.3M trimmed.
- Prostatis Group's largest Q1 2021 buy was iShares ESG Aware MSCI USA ETF: 92,737 shares worth $8.43M.
- Prostatis Group added most to iShares MSCI USA Small-Cap Min Vol Factor ETF in Q1 2021, an estimated $2.61M increase.
- Prostatis Group's biggest Q1 2021 reduction was Vanguard Value ETF, cutting an estimated $10.3M.
- Prostatis Group fully exited Vanguard Intermediate-Term Bond ETF in Q1 2021, selling an estimated $3.87M.
- Prostatis Group's ten largest holdings make up 47% of its $127M portfolio in Q1 2021.
- Prostatis Group opened 27 new positions and closed 7 in Q1 2021.
- Prostatis Group's portfolio value rose 6.7% quarter-over-quarter to $127M.
Based on Prostatis Group's 13F filing for Q1 2021, filed 23 Mar 2023.